We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

58 hedge funds and large institutions have $251M invested in Global Cord Blood Corporation in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

16% more funds holding

Funds holding: 5058 (+8)

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

4% less capital invested

Capital invested by funds: $261M → $251M (-$9.79M)

64% less call options, than puts

Call options by funds: $461K | Put options by funds: $1.28M

Holders
58
Holders Change
+8
Holders Change %
+16%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
20
Increased
15
Reduced
13
Closed
10
Calls
$461K
Puts
$1.28M
Net Calls
-$823K
Net Calls Change
-$1.28M
Name Holding Trade Value Shares
Change
Change in
Stake
VF
26
Virtu Financial
New York
$520K +$180K +17,665 +53%
MWNA
27
Marshall Wace North America
New York
$460K +$461K +45,086 New
Goldman Sachs
28
Goldman Sachs
New York
$409K -$54.7K -5,352 -12%
Acadian Asset Management
29
Acadian Asset Management
Massachusetts
$323K -$383K -37,524 -54%
AR
30
Advisory Research
Illinois
$323K +$63.6K +6,223 +24%
Group One Trading
31
Group One Trading
Illinois
$295K -$114K -11,178 -28%
DI
32
DUMAC Inc
North Carolina
$285K +$285K +27,896 New
JP Morgan Chase
33
JP Morgan Chase
New York
$244K -$953K -93,286 -80%
Wolverine Trading
34
Wolverine Trading
Illinois
$231K +$110K +10,809 +91%
PAM
35
Panagora Asset Management
Massachusetts
$222K +$223K +21,803 New
Russell Investments Group
36
Russell Investments Group
United Kingdom
$209K +$142K +13,922 +211%
ECM
37
Element Capital Management
New York
$205K +$206K +20,126 New
LA
38
Lucus Advisors
New York
$160K -$181K -17,757 -53%
FRM
39
Fox Run Management
Connecticut
$160K +$160K +15,640 New
CSS
40
Cubist Systematic Strategies
Connecticut
$151K +$152K +14,837 New
BlackRock
41
BlackRock
New York
$137K +$137K +13,401 New
PNC Financial Services Group
42
PNC Financial Services Group
Pennsylvania
$132K
TRCT
43
Tower Research Capital (TRC)
New York
$132K +$132K +12,934 New
ACI
44
AMP Capital Investors
Australia
$126K
Commonwealth Equity Services
45
Commonwealth Equity Services
Massachusetts
$117K +$118K +11,550 New
BIM
46
Bogle Investment Management
Massachusetts
$112K -$987K -96,671 -90%
MFW
47
Mosaic Family Wealth
Missouri
$112K -$24.5K -2,400 -18%
Hudson Bay Capital Management
48
Hudson Bay Capital Management
Connecticut
$102K
MML Investors Services
49
MML Investors Services
Massachusetts
$102K
IWM
50
IHT Wealth Management
Illinois
$73K -$48K -4,700 -39%

CO Hedge Fund Activity: Q1 2018 in Review

58 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2018, worth a combined $251M — down 3.8% from $261M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new CO positions and 10 closed out — a net gain of 10 holders — while 15 added to existing stakes and 13 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $12.3M. The largest seller was Skandinaviska Enskilda Banken (SEB), exiting entirely with an estimated $29.2M sold.

  • 58 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2018, up from 50 in Q4 2017.
  • Funds reported $251M of Global Cord Blood Corporation stock for Q1 2018, down 3.8% quarter-over-quarter.
  • 20 funds opened new Global Cord Blood Corporation positions in Q1 2018 and 10 closed out, a net change of +10 holders.
  • The largest Global Cord Blood Corporation buyer in Q1 2018 was Vanguard Group, an estimated $12.3M added.
  • The largest Global Cord Blood Corporation seller in Q1 2018 was Skandinaviska Enskilda Banken (SEB), an estimated $29.2M sold.

Based on aggregated 13F filings for Q1 2018.